Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Focus on Pollinosis (2)
February 13, 2006
- JGPMA to Talk with JPMA About Job Sharing
February 13, 2006
- 2006 Pollen Websites
February 13, 2006
- Nationwide Delivery of Generics Is Possible: Mr Nakagawa
February 13, 2006
- New Prescription Form Taking Shape
February 13, 2006
- Japanese GE Market "a Big Opportunity": Dr Rummelt of Sandoz
February 13, 2006
- Pfizer Receives FDA Approval for New Anticancer Agent
February 13, 2006
- New Guidance Issued on On-site GCP Compliance Inspections
February 13, 2006
- Atypical Antipsychotic Abilify: Otsuka
February 6, 2006
- Proposed Revision of Medical Materials System Approved by Chuikyo
February 6, 2006
- Silodosin to Improve Dysuria: Kissei
February 6, 2006
- MEDICAL DEVICE NEWS IN BRIEF
February 6, 2006
- Femara for Breast Cancer: Novartis
February 6, 2006
- JSMI to Submit Petition on Self-medication to Korosho
February 6, 2006
- 3 Drugs, 1 Diagnostic Recommended for Approval
February 6, 2006
- Group of Pharmacy Chains Calls For Sale of Drugs via Internet
February 6, 2006
- Toyama, Nidek Granted Approval for Tosufloxacin Eye Drops
February 6, 2006
- Sysmex to Shift Focus to Disease Management
February 6, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 6, 2006
- Serono Japan Granted Approval for Follitropin a to Treat MHH
February 6, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…